Literature DB >> 9745599

CD4 lymphocytopenia in long-term renal transplant recipients.

D Ducloux1, P L Carron, E Racadot, J M Rebibou, C Bresson-Vautrin, Y Saint-Hillier, J M Chalopin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9745599     DOI： 10.1016/s0041-1345(98)00843-4

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  5 in total

1.  Prolonged CD4 T cell lymphopenia increases morbidity and mortality after renal transplantation.

Authors:  Didier Ducloux; Cécile Courivaud; Jamal Bamoulid; Bérengère Vivet; Aline Chabroux; Marina Deschamps; Jean-Michel Rebibou; Christophe Ferrand; Jean-Marc Chalopin; Pierre Tiberghien; Philippe Saas
Journal:  J Am Soc Nephrol       Date:  2010-03-04       Impact factor: 10.121

Review 2.  Cancer prevention in HIV-infected populations.

Authors:  Priscila H Goncalves; Jairo M Montezuma-Rusca; Robert Yarchoan; Thomas S Uldrick
Journal:  Semin Oncol       Date:  2015-09-08       Impact factor: 4.929

3.  Cutaneous malignancies among HIV-infected persons.

Authors:  Nancy Crum-Cianflone; Katherine Huppler Hullsiek; Elizabeth Satter; Vincent Marconi; Amy Weintrob; Anuradha Ganesan; R Vincent Barthel; Susan Fraser; Brian K Agan
Journal:  Arch Intern Med       Date:  2009-06-22

4.  [Thymoglobulin as induction treatment in kidney transplantants with low immunological risk: a Moroccan experience].

Authors:  Zineb Abouzid; Mohamed Anass Amar; Maher Abdessater; Meryem Alioubane; Anissa Benjaafar; Naima Ouzeddoun; Loubna Benamar; Rabia Bayahia; Tarik Bouattar
Journal:  Pan Afr Med J       Date:  2022-02-17

5.  Risk factors for impaired CD4+ T-cell reconstitution following rabbit antithymocyte globulin treatment in kidney transplantation.

Authors:  Hélène Longuet; Bénédicte Sautenet; Philippe Gatault; Gilles Thibault; Christelle Barbet; Jean-Frédérique Marliere; Jean-Michel Halimi; Yvon Lebranchu; Christophe Baron; Matthias Büchler
Journal:  Transpl Int       Date:  2013-12-27       Impact factor: 3.782
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.